What is Dario?
Dario operates at the intersection of behavioral science and digital health, providing a comprehensive ecosystem for chronic condition management and general well-being. The company distinguishes itself through a highly personalized, dynamic member experience that adapts to individual health needs in real-time. By utilizing billions of data points, Dario facilitates lasting behavioral change, which translates into measurable clinical and financial outcomes for its partners. Its platform is designed to integrate seamlessly into existing healthcare infrastructures, making it a preferred choice for organizations seeking to improve member engagement and long-term health outcomes.
How much funding has Dario raised?
Dario has raised a total of $113.6M across 4 funding rounds:
Share Placement
$28.6M
Debt
$50M
Stock/Share Issuance
$17.5M
Stock/Share Issuance
$17.5M
Share Placement (2020): $28.6M with participation from Mor provident fund, Nantahala Capital Management, LLC, Manchester Management Company LLC, Psagot investment house, Phoenix insurance, and Soleus Capital Management L.P.
Debt (2022): $50M led by OrbiMed
Stock/Share Issuance (2025): $17.5M, investors not publicly disclosed
Stock/Share Issuance (2025): $17.5M, investors not publicly disclosed
Key Investors in Dario
OrbiMed
OrbiMed is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and digital health platforms to support innovation at various development stages.
Nantahala Capital Management, LLC
Nantahala Capital Management is an investment firm that provides strategic backing to growth-stage companies, often focusing on long-term value creation within the technology and healthcare sectors.
Soleus Capital Management L.P.
Soleus Capital Management is a dedicated healthcare investment firm that partners with innovative companies to drive clinical advancements and commercial success through strategic capital deployment.
What's next for Dario?
With this latest capital injection, Dario is well-positioned to expand its enterprise footprint and enhance its proprietary data analytics capabilities. The strategic focus will likely shift toward deepening its integration within the broader healthcare ecosystem, potentially targeting new therapeutic areas and scaling its clinical support services. As the demand for remote, connected health solutions continues to rise, Dario's commitment to high-impact, evidence-based interventions will be pivotal in maintaining its competitive edge. The company is expected to prioritize operational efficiency and market penetration, ensuring that its digital health solutions remain at the forefront of the industry's transition toward value-based care models.
See full Dario company page
